A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells

BACKGROUND: Evading apoptosis by overexpression of anti-apoptotic Bcl-2 family proteins is a hallmark of cancer cells and the Bcl-2 selective inhibitor venetoclax is widely used in the treatment of hematologic malignancies. Mcl-1, another anti-apoptotic Bcl-2 family member, is recognized as the prim...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Tianming, He, Qiang, Xie, Shurong, Zhan, Huien, Jiang, Cheng, Lin, Shengbin, Liu, Fangshu, Wang, Cong, Chen, Guo, Zeng, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854187/
https://www.ncbi.nlm.nih.gov/pubmed/36658493
http://dx.doi.org/10.1186/s10020-022-00565-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854187/
https://www.ncbi.nlm.nih.gov/pubmed/36658493
http://dx.doi.org/10.1186/s10020-022-00565-7

Ejemplares similares